Delayed Emergence Due to Prolonged Mivacurium Blockade in a Child with Markedly Reduced Butyrylcholinesterase Activity: A Case Report.
4 affiliations
- 1Department of Anaesthesia and Intensive Care, Riga Stradiņš University, LV-1007 Riga, Latvia.
- 2Department of Anaesthesiology, Intensive Care and Pain Management, Riga 1st Hospital, LV-1001 Riga, Latvia.
- 3Vītola Clinic, LV-1045 Riga, Latvia.
- 4Department of Intensive Care, Children's Clinical University Hospital, LV-1004 Riga, Latvia.
Abstract
Background: Delayed emergence after general anesthesia in pediatric patients is uncommon and requires prompt evaluation of pharmacological, metabolic, and neurological causes. Residual neuromuscular blockade remains an important reversible cause, particularly when short acting neuromuscular blocking agents dependent on plasma cholinesterase metabolism are used. Case report: We report the case of a previously healthy three-year-old boy who underwent elective adenoidectomy, tonsillotomy, and tympanostomy under general anesthesia with fentanyl, propofol, sevoflurane, and mivacurium. Following the procedure, the patient failed to regain spontaneous breathing, purposeful movements, or response to painful stimuli. In response, neostigmine was administered to reverse possible residual neuromuscular blockade; however, no immediate clinical improvement was observed, and mechanical ventilation was continued. Quantitative neuromuscular monitoring was unavailable. Therefore, residual blockade could not be objectively assessed, and the depth of blockade at the time of neostigmine administration remained unknown. The patient was transferred to a tertiary pediatric center for further evaluation. Several hours later, spontaneous breathing and motor activity recovered, and the patient was successfully extubated. Retrospective family history revealed prolonged recovery after anesthesia in the patient's grandfather. Subsequent laboratory testing demonstrated markedly reduced plasma butyrylcholinesterase activity (2493 U/L; reference range 7000-19,000 U/L), raising a strong suspicion of inherited butyrylcholinesterase deficiency. Conclusions: This case highlights the importance of considering residual neuromuscular blockade in delayed emergence after pediatric anesthesia, maintaining airway protection, and obtaining relevant family history to guide future management.
Related
- Prediction of emergence from the minimally conscious state at 6 months using acute-phase clinical and event-related potential indicators in patients with prolonged disorders of consciousness: a single-center retrospective cohort study
- Design, synthesis, and docking analysis of benzene sulfonamide-[1,4]benzoxazepine hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors
- Differential Modulation of Serum Albumin and Butyrylcholinesterase Following Pemafibrate Treatment in MASLD: A Post Hoc Analysis of the PEMA-FL Trial
- Case Report: Prostatic infarction mimicking prostate cancer in a patient with markedly elevated prostate-specific antigen
- Markedly Delayed Onset ICANS in the Setting of CAR T-Cell-Mediated Aseptic Meningoencephalitis: Two Cases
BibTeX
@article{saburova2026delayed,
title = {{Delayed Emergence Due to Prolonged Mivacurium Blockade in a Child with Markedly Reduced Butyrylcholinesterase Activity: A Case Report.}},
author = {Daniela Saburova and Rihards Peteris Rocans and Irina Evansa and Arta Barzdina and Inna Babuskina and Natalija Zlobina and Olegs Sabelnikovs},
journal = {Clinics and practice},
year = {2026},
month = oct,
doi = {10.3390/clinpract16100186},
url = {https://europepmc.org/article/MED/42930372},
note = {CC BY},
}
RIS
TY - JOUR
TI - Delayed Emergence Due to Prolonged Mivacurium Blockade in a Child with Markedly Reduced Butyrylcholinesterase Activity: A Case Report.
AU - Daniela Saburova
AU - Rihards Peteris Rocans
AU - Irina Evansa
AU - Arta Barzdina
AU - Inna Babuskina
AU - Natalija Zlobina
AU - Olegs Sabelnikovs
PY - 2026
DA - 2026/10/09
JO - Clinics and practice
DO - 10.3390/clinpract16100186
UR - https://europepmc.org/article/MED/42930372
AB - Background: Delayed emergence after general anesthesia in pediatric patients is uncommon and requires prompt evaluation of pharmacological, metabolic, and neurological causes. Residual neuromuscular blockade remains an important reversible cause, particularly when short acting neuromuscular blocking agents dependent on plasma cholinesterase metabolism are used. Case report: We report the case of a previously healthy three-year-old boy who underwent elective adenoidectomy, tonsillotomy, and tympanostomy under general anesthesia with fentanyl, propofol, sevoflurane, and mivacurium. Following the procedure, the patient failed to regain spontaneous breathing, purposeful movements, or response to painful stimuli. In response, neostigmine was administered to reverse possible residual neuromuscular blockade; however, no immediate clinical improvement was observed, and mechanical ventilation was continued. Quantitative neuromuscular monitoring was unavailable. Therefore, residual blockade could not be objectively assessed, and the depth of blockade at the time of neostigmine administration remained unknown. The patient was transferred to a tertiary pediatric center for further evaluation. Several hours later, spontaneous breathing and motor activity recovered, and the patient was successfully extubated. Retrospective family history revealed prolonged recovery after anesthesia in the patient's grandfather. Subsequent laboratory testing demonstrated markedly reduced plasma butyrylcholinesterase activity (2493 U/L; reference range 7000-19,000 U/L), raising a strong suspicion of inherited butyrylcholinesterase deficiency. Conclusions: This case highlights the importance of considering residual neuromuscular blockade in delayed emergence after pediatric anesthesia, maintaining airway protection, and obtaining relevant family history to guide future management.
SN - 2039-7275
SN - 2039-7283
ER -